Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Tables)

v3.20.4
Share-based Compensation (Tables)
9 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Activity for Stock Options
The following table summarizes activity for stock options during the period ended December 31, 2020:
Number of Options
Weighted Average
Exercise Price
Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands) (per share) (years) (in thousands)
Balance, March 31, 2020 7,147  $ 16.26  9.3 $ 54,423 
Granted 2,305  33.55 
Exercised (427) 16.05 
Forfeited (300) 17.91 
Balance, December 31, 2020 8,725  $ 20.78  8.8 $ 196,185 
Options vested and exercisable at December 31, 2020 1,718  $ 16.18  8.6 $ 46,538 
Summary of Activity for Restricted Shares
The following table provides a summary of the changes in the number of restricted shares for the period ended December 31, 2020:
Number of Shares of
Restricted Stock Awards
Weighted Average
Grant Date Fair Value
Number of Restricted Stock Units Weighted Average
Grant Date Fair Value
(in thousands) (per share) (in thousands) (per share)
Balance, March 31, 2020 1,984  $ 16.00  3,123  $ 16.39 
Granted —  —  1,285  33.73 
Vested (1,009) 16.00  (1,036) 16.15 
Forfeited (103) 16.00  (148) 18.70 
Balance, December 31, 2020 872  $ 16.00  3,224  $ 23.27 
Schedule of Share-based Compensation Expense
The following table summarizes the components of total share-based compensation expense included in the condensed consolidated financial statements for each period presented (in thousands):
Three Months Ended December 31, Nine Months Ended December 31,
2020 2019 2020 2019
Cost of revenue $ 2,066  $ 1,317  $ 5,430  $ 17,346 
Research and development 3,259  2,173  8,666  36,679 
Sales and marketing 6,480  6,707  18,007  78,592 
General and administrative 3,783  3,316  10,988  77,067 
Total share-based compensation expense $ 15,588  $ 13,513  $ 43,091  $ 209,684